NCT04282629View on ClinicalTrials.gov

Cerebral Hemodynamic Optimization by Milrinone to Prevent Delayed Cerebral Ischemia

PHASE2RecruitingINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

July 25, 2021

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Aneurysmal Subarachnoid Hemorrhage
Interventions
DRUG

Milrinone Injection

administration of milrinone (0.75 μg / kg / min, intravenous) from Day 4 to Day 14

OTHER

Placebo

administration of placebo (intravenous glucose 5%) from Day 4 to Day 14

Trial Locations (5)

Unknown

ACTIVE_NOT_RECRUITING

University Hospital Bordeaux, Bordeaux

ACTIVE_NOT_RECRUITING

CHUGA, Grenoble

RECRUITING

University Hospital of La Réunion, La Réunion

RECRUITING

HCL, Lyon

RECRUITING

University Hospital of Toulouse, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER